11 results match your criteria: "University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital[Affiliation]"

We report a nosocomial outbreak caused by a multidrug-resistant carbapenemase-producing Klebsiella pneumoniae (MDRCPKp), that was detected in six patients admitted to the medical intensive care unit between 20th of December 2023 and 15th of January 2024 in Ankara, Turkey. The investigation of this outbreak was started on 29th of December 2023. During the outbreak 11 samples were collected from the six patients with MDRCPKp.

View Article and Find Full Text PDF

Introduction: Healthcare workers are at high risk for acquiring COVID-19 and transmitting it to the patients especially to cancer patients in whom the risk of severe COVID-19 is high. We determined the rate of COVID-19 infection among healthcare workers in an oncology hospital and their epidemiological characteristics.

Methodology: Data of infected workers from March 11, 2020, to February 28, 2022 were obtained via Infection Control Committee COVID-19 Surveillance Records and evaluated retrospectively.

View Article and Find Full Text PDF

Purpose: To determine the active treatment option and perioperative complications using the 5-Factor Modified Frailty Index (mFI-5) in localized prostate cancer patients.

Material And Methods: Patients diagnosed with localized prostate cancer in our clinic between January 2018 and October 2022 were evaluated. The patients were separated according to the mFI-5 scores as Group 1 (score = 0, n = 74), Group 2 (score = 1, n = 41), and Group 3 (score ≥ 2, n = 69).

View Article and Find Full Text PDF

Purpose: The aim of this study was to examine the effect of kidney tumor size on the risk of CPE developing in the first postoperative month.

Material And Methods: Evaluation was made of 127 patients who underwent PN between January 2010 and November 2022. The patients were separated into two groups as Group 1 (n: 13) including patients who developed CPE within the first postoperative month and Group 2 (n: 114) of patients who did not develop CPE.

View Article and Find Full Text PDF

Objective: The aim of this study is to investigate the relationship between histogram parameters and prognostic factors of breast cancer and to reveal the diagnostic performance of histogram parameters in predicting prognostic factors status.

Materials And Methods: Ninety-two patients with a confirmed histopathological diagnosis of breast cancer were included in the study. Magnetic resonance imaging (MRI) was performed using a 1.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to analyze the effectiveness of adding pertuzumab (P) to trastuzumab (H) and neoadjuvant chemotherapy (NCT) in achieving pathological complete response (pCR) in HER2+ breast cancer patients.
  • - Involving 1,528 female patients, the results showed that those receiving NCT-HP had a significantly higher pCR rate (66.4%) compared to those on NCT-H (56.8%) and fewer relapses (4.5% vs. 12.2%).
  • - Key factors predicting pCR included invasive ductal carcinoma type, lower tumor grades, and the use of paclitaxel, reinforcing the benefits of adding pertuzumab in
View Article and Find Full Text PDF

Objective: In this study, we aimed to reveal the general clinicopathological features, treatment features, and factors that could predict overall survival in metastatic soft tissue sarcomas, a very rare and heterogeneous disease group.

Patients And Methods: This study was a retrospective cohort study. Patients monitored with metastatic soft tissue sarcoma between January 2001 and January 2021 were evaluated retrospectively.

View Article and Find Full Text PDF

Objective: In the treatment of metastatic colorectal cancer (mCRC), there is a need for a treatment option in patients who have received regorafenib (RGR) therapy and progressed, especially in patients fit enough to receive a new therapy. We aimed to compare the role of rechallenge chemotherapy (RCH CTx) with best supportive care (BSC) in mCRC patients after standard CTx and subsequent RGR treatment in terms of survival benefit.

Patients And Methods: Patients with progressive mCRC who received at least one month of subsequent RGR therapy after standard CTx treatments were included in the study.

View Article and Find Full Text PDF

Introduction: Patients treated in the intensive care unit (ICU) are usually patients who deteriorated health condition and could have longer hospital stay compared to other patients. Hospital infections are more common in ICU patients. The aim of this study was to evaluate the bacteria and treatment resistance profiles isolated from clinical specimens sent for hospital infections in ICU patients between January 1, 2014 and December 31, 2018.

View Article and Find Full Text PDF

Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies.

J Infect Dev Ctries

August 2019

University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey.

Introduction: Patients with hematological malignancies, who are in the high risk group for infectious complications and bacterial bloodstream infections. The aim of the study evaluated epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. In addition to determine the risk factors, changes in the distribution and frequency of isolated bacterias.

View Article and Find Full Text PDF

Objectives: To analyze the tuberculosis control studies in a primary health care center and to observe the changes throughout the years.

Materials And Methods: Data of patients followed up between 2005 and 2014 in the Elazığ Dispensary were investigated retrospectively.

Results: Of the total 1,251 patients, 51.

View Article and Find Full Text PDF